(Q38803189)

6 September 2017

4 June 2022

0 references

Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies (English)

1 reference

National Institute for Occupational Safety and Health

6 September 2017

sponsor

1 reference

4 June 2022

1 reference

1 reference

1 reference

1 reference

Influenza

1 reference

4 June 2022

Infectious diseases

1 reference

4 June 2022

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061888%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Jennifer P King

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061888%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

6

Michael T Osterholm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061888%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

7

Huong Q McLean

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061888%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

4

Maria E Sundaram

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061888%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

5

Nicholas S Kelley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061888%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Melissa D Simpson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061888%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

1 reference

inferred from title

process of elimination

publication date

6 April 2016

1 reference

Lancet Infectious Diseases

6 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061888%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061888%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061888%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

942-951

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061888%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

performing organization

University of Minnesota

object named as

University of Minnesota Twin Cities

1 reference

NIOSHTIC-2

on focus list of Wikimedia project

2 February 2024

Wikimedia–NIOSH collaboration

0 references

1 reference

25 September 2023

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

The case test-negative design for studies of the effectiveness of influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

The test-negative design for estimating influenza vaccine effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Estimating influenza vaccine effectiveness using routinely collected laboratory data.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Assessment of the variability in influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approach

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method--experience across the 2010/11 season.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

The impact of influenza epidemics on mortality: introducing a severity index.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Mapping the antigenic and genetic evolution of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Influenza virus surveillance, vaccine strain selection, and manufacture

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021

Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900129-8

7 January 2021